UBE2K and Parkinson disease: To address these questions, we first generated HIP2 haploinsufficient mice using CRISPR-Cas9 gene editing, and characterized their motor functions and pathologic features in the 6-hydroxydopamine (6-OHDA) toxicity model for PD.